ArticleInternational ophthalmology2025
Long-term outcomes of the Şimşek technique vs long scleral tunnel method in Ahmed glaucoma valve implantation.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the long-term outcomes of the Şimşek technique, a modified Ahmed Glaucoma Valve (AGV) implantation using a scleral tunnel created with a 6-0 Prolene suture.
methodsThis retrospective, comparative study was conducted at a tertiary referral center and included glaucoma patients who underwent AGV implantation via either the Şimşek technique (Group 1) or the classic long scleral tunnel technique (Group 2), with at least 12 months of follow-up. Group 1 included 44 patients (mean age: 54.8 ± 19.3 years), and Group 2 consisted of 48 patients (mean age: 50 ± 22.8 years). Pre- and postoperative assessments included best-corrected visual acuity (BCVA), intraocular pressure (IOP), number of anti-glaucomatous medications (NAGM), surgical success, and complications.
resultsMean follow-up duration was 22.6 ± 7.6 months in Group 1 and 27.3 ± 14.9 months in Group 2. No statistically significant differences were found between groups in IOP reduction (p = 0.237), NAGM at final visit (p = 0.054), or surgical success (p = 0.79). Complication rates were 54.5% in Group 1 and 56.3% in Group 2 (p = 1.000). Notably, no cases of tube exposure were observed in Group 1. Group 1 showed a significant improvement in BCVA compared to Group 2 (p = 0.003).
conclusionsThe Şimşek Technique yielded comparable IOP control and surgical success to the conventional method, with significantly improved BCVA and reduced tube exposure risk. These findings suggest its suitability, especially in patients with thin conjunctiva or where visual function preservation is critical. Further prospective studies are warranted.
Indexed as
Identifiers
41405653What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.